Previous 10 | Next 10 |
2023-05-11 14:34:03 ET Summary Today, we peek back in on Rocket Pharmaceuticals, Inc. for the first time in 2023. The company is seeing some momentum from positive trial developments and new-found enthusiasm from the analyst community so far here in May. An investment analysis...
First clinical gene therapy program for PKP2-ACM, a devastating inherited heart disease affecting approximately 50,000 people in the U.S. and EU Robust preclinical proof of concept studies showed RP-A601 decreased arrhythmias and increased survival in the PKP2 knockout mouse model ...
2023-04-21 15:00:36 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...
2023-04-14 13:30:11 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch for a full list of events planned for the week or the Seeking Alpha earnings calendar for com...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that Company management will participate in the 22nd Annual Needham Virtual Heal...
Jonathan Schwartz, M.D., appointed Chief Gene Therapy Officer to enhance the Company’s focus on strategic application of gene therapy technologies to current and future therapeutic areas Mark White, MB.ChB, named Chief Medical Officer; Dr. White brings proven track record in late-s...
2023-03-18 01:44:45 ET Summary The first and original spin on stock market investing meshed with the thrill of the NCAA March Madness tournament! Which "team" (Asset Class) wins out the rest of 2023? Will active or passive be the answer? March Madness is back! No...
2023-03-10 12:20:27 ET Rocket Pharmaceuticals ( NASDAQ: RCKT ) said Friday that it does not hold any cash deposits or securities at FDIC-seized Silicon Valley Bank ( SIVB ). Rocket shares ( RCKT ) are down 8% in Friday afternoon trading. The downfall of...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that Gaurav Shah, M.D., Chief Executive Officer, is scheduled to participate in ...
Rocket Pharmaceuticals press release ( NASDAQ: RCKT ): Q4 GAAP EPS of -$0.92 misses by $0.10 . Cash, cash equivalents and investments of approximately $400M; expected operational runway through 2024 For further details see: Rocket Pharmaceuticals GAAP EPS of -$0.92 m...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
11.34%Change Percent:
Rocket Pharmaceuticals Inc. Company Name:
RCKT Stock Symbol:
NASDAQ Market:
Rocket Pharmaceuticals Inc. Website:
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet needs, today announced a regulatory update for KRESLADI™ (marnetegragene autotemcel; marne-cel), a le...
2024-06-02 14:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the European Commission (EC), based on a positive opinion issued by the Committ...